Dow Up 0.76% Nasdaq Up 0.69%

RXi Pharmaceuticals Corporation (RXII)

-NasdaqCM
2.06 Up 0.12(6.19%) 4:00PM EDT
Prev Close:1.94
Open:1.93
Bid:1.80 x 100
Ask:N/A
1y Target Est:10.17
Beta:2.04
Next Earnings Date:N/A
Day's Range:1.93 - 2.12
52wk Range:1.64 - 6.84
Volume:122,276
Avg Vol (3m):518,940
Market Cap:33.17M
P/E (ttm):N/A
EPS (ttm):-1.16
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for RXII

Comparison

Symbol% ChgMkt Cap
RXIIUp 6.19%33.17M
AGNUp 0.46%54.74B
ALNYUp 2.21%7.17B
MRNAUp 2.94%22.49M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):192.84
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.95
Quarterly EPS Est (Sep-14) :-0.22
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

RXi Pharmaceuticals Corporation, a biotechnology company, focuses on discovering, developing, and commercializing therapies based on its proprietary, next-generation RNA interference (RNAi) platform. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback